An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells

被引:37
作者
Aaronson, David S.
Muller, Melissa
Neves, Susana R.
Chung, Wen-Chen
Jayaram, Gomathi
Iyengar, Ravi
Ram, Prahlad T.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA
[2] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY USA
关键词
EGF; Stat3; prostate cancer; IL-6; signaling network;
D O I
10.1016/j.mce.2007.02.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dynamic modulation of information flow within signaling networks allows the cell to respond to micro-environmental changes. This property of the cell, while being essential to survival and eliciting appropriate responses, can also be detrimental to the organism by allowing cancerous cells to evade regulation and proliferate. We determined if changes in expression levels of transcriptional regulators and their interactions could alter routing within signaling networks in prostate cancer cells. Increasing the protein levels of the signal transducer and activator of transcription 3 (Stat3) led to Stat3-androgen receptor (AR) complex formation in response to epidermal growth factor (EGF) and interleukin-6 (IL-6) stimulation. Increasing the protein levels of Stat3 increased the EGF induced transcriptional activation of the androgen receptor. Androgen pre-treatment increased Stat3 protein levels in an IL-6 autocrine/paracrine dependent manner in the cells suggesting a feedback loop within cells. Increased Stat3-AR complex leads to a change in the routing of the epidermal growth factor signal allowing the androgen receptor to become activated in a Stat3 dependent manner. Understanding interactions and changes in signal flow within the cell is important to our understanding of signaling networks as well as our ability to identify cellular targets for novel therapies to inhibit cancer progression. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 28 条
  • [21] Autocrine effect of androgen on proliferation of an androgen responsive prostatic carcinoma cell line, LNCaP: Role of interleukin-6
    Okamoto, M
    Lee, C
    Oyasu, R
    [J]. ENDOCRINOLOGY, 1997, 138 (11) : 5071 - 5074
  • [22] Interleukin-6 and prostate cancer progression
    Smith, PC
    Hobisch, A
    Lin, DL
    Culig, Z
    Keller, ET
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2001, 12 (01) : 33 - 40
  • [23] Functional interactions between Stat5 and the glucocorticoid receptor
    Stocklin, E
    Wissler, M
    Gouilleux, F
    Groner, B
    [J]. NATURE, 1996, 383 (6602) : 726 - 728
  • [24] Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
    Ueda, T
    Mawji, NR
    Bruchovsky, N
    Sadar, MD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 38087 - 38094
  • [25] Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
    Ueda, T
    Bruchovsky, N
    Sadar, MD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) : 7076 - 7085
  • [26] Ligand-independent activation of steroid hormone receptors
    Weigel, NL
    Zhang, YX
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (07): : 469 - 479
  • [27] Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells
    Yang, L
    Wang, L
    Lin, HK
    Kan, PY
    Xie, SZ
    Tsai, MY
    Wang, PH
    Chen, YT
    Chang, CS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (03) : 462 - 469
  • [28] Zhang XK, 1999, MOL CELL BIOL, V19, P7138